Funder
Deanship of Scientific Research, King Khalid University
Publisher
Springer Science and Business Media LLC
Reference137 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F, Global Cancer Statistics 2020. GLOBOCAN estimates of incidence and mortality Worldwide for 36 cancers in 185 Countries. CA: Canc J Clin. 2021;71:209–49.
2. Fodale V, Pierobon M, Liotta L, Petricoin E. Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance? Cancer J (Sudbury Mass). 2011;17:89–95.
3. Xu XC. COX-2 inhibitors in cancer treatment and prevention, a recent development. Anticancer Drugs. 2002;13:127–37.
4. Wang D, Guo XZ, Li HY, Zhao JJ, Shao XD, Wu CY. Prognostic significance of cyclooxygenase-2 protein in Pancreatic cancer: a meta-analysis. Tumour Biol. 2014;35:10301–7.
5. Li S, Jiang M, Wang L, Yu S. Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: recent advancement. Biomed Pharmacother. 2020;129:110389.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献